4343-73-1

Basic information

• Product Name: ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate
• Synonyms: ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate;Ethyl-5-methyl-1H-1,2,3-triazol-4-carboxylat;2,3-triazole-4-carboxylic acid, 5-methyl-1h- ethyl ester;2,3-triazole-4-carboxylic acid, 5-methyl-1h- ethylester;5-Methyl-1H-1,2,3-triazole-4-carboxylic acid ethyl ester;1H-1,2,3-Triazole-4-carboxylic acid, 5-methyl-, ethyl ester;Einecs 224-401-7;Ethyl 4-methyl-2H-1,2,3-triazole-5-carboxylate
• CAS NO: 4343-73-1
• Molecular Formula: C₆H₉N₃O₂
• Molecular Weight: 155.15456
• EINECS: 224-401-7
• Mol File: 4343-73-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 287.1°Cat760mmHg
• Flash Point: 127.5°C
• Appearance: /
• Density: 1.242g/cm³
• Vapor Pressure: 0.00253mmHg at 25°C
• Refractive Index: 1.522
• CAS DataBase Reference: ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate(4343-73-1)
• EPA Substance Registry System: ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate(4343-73-1)

Safety Data

• Hazardous Substances Data: 4343-73-1(Hazardous Substances Data)

Usage

General Description

Ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate is a chemical compound with the molecular formula C7H9N3O2. It is a derivative of 1,2,3-triazole and is commonly used in the synthesis of pharmaceuticals and agrochemicals. ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate has a wide range of applications, including as a building block in the production of antifungal, antiviral, and antitumor agents. It can also be used as a precursor in the synthesis of various organic compounds. Ethyl 5-methyl-1H-1,2,3-triazole-4-carboxylate is a versatile chemical that is valuable in the field of organic chemistry and drug development.

InChI:InChI=1/C6H9N3O2/c1-3-11-6(10)5-4(2)7-9-8-5/h3H2,1-2H3,(H,7,8,9)

Upstream product

• 64-17-5 ethanol 
• 2009-97-4 ethyl 2-diazo-3-oxobutanoate 
• 631-61-8 ammonium acetate 
• 141-97-9 ethyl acetoacetate 
• 4093-60-1 ethyl 3-[(2,4-dinitrophenyl)hydrazono]butanoate 
• 942060-21-1 1-(4-methoxybenzyl)-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester 
• 942060-22-2 3-(4-methoxy-benzyl)-5-methyl-3H-[1,2,3]triazole-4-carboxylic acid ethyl ester 
• 832737-27-6 5-methyl-2H-1,2,3-triazole-4-carboxylic acid 
• 4341-76-8 Ethyl 2-butynoate 
• 4648-54-8 trimethylsilylazide 

Relevant articles and documents

SUBSTITUTED TETRAHYDROCYCLOPENTA[C]PYRROLES, SUBSTITUTED DIHYDROPYRROLIZINES, ANALOGUES THEREOF, AND METHODS USING SAME

The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection and/or hepatitis D virus (HDV) infection in a patient.

SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS

Disclosed are compounds of Formula (I) or a salt thereof, wherein R1 is (II) or (III); each W is independently NR1b or O; Z is a bond or CHR1d; and R1, R2, Rd, R3, L1, L2, R1a, R1b, R1c, and n are define herein. Also disclosed are methods of using such compounds as inhibitors of ROMK, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating cardiovascular diseases.

TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE

The present invention provides compounds of Formula (I): wherein A and R1 are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.